Insoluble corn fiber compostion
The insoluble corn fiber composition with optimized particle size and bioactive compound content addresses sub-optimal bioaccessibility in existing products, enhancing health benefits and cost-effectiveness for meat alternatives.
Patent Information
- Application Number
- PCT/US2024/030576
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-25
- Filing Date
- 2024-05-22
- Publication Date
- 2024-11-28
AI Technical Summary
The bioaccessibility of bioactive compounds in existing plant-based insoluble fiber compositions is sub-optimal, limiting their health benefits, and there is a demand for cost-effective, label-friendly alternatives to meat in processed and plant-based meat products that can mimic sensory properties of meat.
A composition comprising at least 50wt% insoluble corn fiber with a D50 particle size of less than or equal to 290pm, enriched with hydroxy cinnamic acids, hydroxybenzoic acids, and steryl ferulates, which are released effectively during in vitro digestion, and can be used in processed meats and plant-based products.
The composition enhances the bioaccessibility of bioactive compounds, providing superior health benefits and improved nutritional profiles in food products, while being cost-effective and suitable for various meat alternatives.
Smart Images

Figure US2024030576_28112024_PF_FP_ABST
Abstract
Description
INSOLUBLE CORN FIBER COMPOSTIONCROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of U.S. Provisional Application No. 63 / 504,372, filed May 25, 2023, which is incorporated by reference herein in its entirety.FIELD OF THE INVENTION
[0002] The present invention relates to a composition rich in insoluble com fiber having improved bioaccessibility of bioactive compounds, which can be used in processed meats, plantbased meat alternative products and in hybrid restructured meat products.BACKGROUND OF THE INVENTION
[0003] Regular intake of insoluble fibers has been shown to lower risk of gastrointestinal diseases, such as irritable bowel syndrome (IBS). In addition, the role of insoluble fibers in lowering the risk of diverticulitis, constipation, and managing weight loss is becoming increasingly known. Food manufacturers are thus looking to include insoluble fibers in their products in order to appeal to the ever more health-driven consumer.
[0004] There is also increasing demand for plant-based insoluble fibers. Insoluble corn fiber (also referred to as com hull fiber or com bran fiber) obtained from the com wet milling process has potential to fill that demand. Insoluble corn fiber can be extracted from corn, mainly from the tough fibrous outer layer or hull of the corn kernel or com bran. This fiber is high in lignocellulosic components with cellulose and hemicellulose making up the majority of the composition. Insoluble corn fiber refers herein to both low and high molecular weight insoluble dietary fibers found in com. Insoluble corn fiber comprises at least 50 wt.% on a dry weight basis of hemicellulose and at least 20 wt.% on a dry weight basis of cellulose and preferably lignin.
[0005] Certain bioactive compounds and micronutrients that are present in insoluble corn fiber are known to have health benefits, such as antioxidant, anti-inflammatory, anti-microbial or prebiotic effects, a lipid / cholesterol lowering effect, or a cardiometabolic function. Importantly, bioactive compounds must be released from the food matrix in the gastrointestinal tract (i.e., become bioaccessible) in order to achieve their beneficial health effects. The bioaccessibility of bioactive compounds and micronutrients in known plant-based insoluble fiber compositions is sub-optimal.
[0006] WO 2022 / 060992 Al discloses an insoluble corn fiber composition having good water absorption capacity, which can be used in processed meats and plant-based meat alternatives. The composition described therein has a D50 particle size of 300pm to 700pm, preferably from 400pm to 600pm.
[0007] Food manufacturers are looking to replace expensive meat-based constituents in processed meats, such as sausages. They are also adapting to growing trends of vegetarian and flexitarian diets to prepare plant-based meat alternatives or plant / meat hybrids with sensory properties similar to the full meat products. These manufactures require label-friendly, cost attractive, plant-based alternatives.
[0008] The present invention aims to fulfil the above demands by providing a food-grade insoluble corn fiber composition having improved bioaccessibility of healthy bioactive compounds and micronutrients, which is suitable for use in manufacturing processed meats.SUMMARY OF THE INVENTION
[0009] A composition is provided comprising at least 50wt% insoluble corn fiber on a dry weight basis or consisting (essentially) of insoluble com fiber, and having a D50 particle size of less than or equal to 290pm. Preferably, the D50 particle size is less than or equal to 180pm or 150pm.
[0010] The composition may comprise less than 10,000ppm total hydroxy cinnamic acids on dry weight basis; and greater than 30ppm total hydroxybenzoic acids on a dry weight basis; and greater than 1, lOOppm total steryl ferulates on a dry weight basis. Said hydroxy cinnamic acids may be selected from ferulic acid, coumaric acid, caffeic acid, chlorogenic acid, and / or combinations thereof. Said hydroxybenzoic acids may be selected from gallic acid, sinapic acid, syringic acid, and vanillic acid, and / or combinations thereof. Said steryl ferulates may be selected from campestanyl ferulate, oryzanol - campesteryl ferulate, oryzanol C -24 - methylenecycloartanyl ferulate, sitosteryl ferulate, and / or combinations thereof.
[0011] According to measurement method 2 (as described herein), at least 60% of each steryl ferulate present in the composition may be released within 360 minutes of in vitro digestion.
[0012] According to measurement method 2 (as described herein), at least 60% of the oryzanol - campesteryl ferulate present in the composition may be released within 360 minutes of in vitro digestion; and / or at least 65% of the oryzanol C -24 - methylenecycloartanyl ferulate present in the compositon may be released within 360 minutes of in vitro digestion.
[0013] The composition may comprise one or more antioxidant compounds. Said antioxidant compounds may be selected from Di-isooctyl sebacate, pyrogallol, sanggenol O, Macrophyllol A (flavone), (9R, 10S-rel-(-)9, 10-bis (Acetyloxy)-9, 10 dihydro-5-methoxy-8,8- dimethyl-2-phenyl-4H,8H-benzo[l,2-b:3,4-b’]dipyran-4-one, 2-Tolylbiguanide, Pyruvic acid, 5- )-Methylchamanetin, phenolic acids, steryl ferulates, or combinations thereof.
[0014] The composition may have antioxidant activity of at least 100 pmol Trolox equivalent / g at or after 3 hours of in vitro digestion according to measurement method 3 (as described herein).
[0015] The composition may be entirely obtainable from a side-stream from the wetmilling processing of com.
[0016] Also provided is a food product comprising the aforementioned composition and one or more other food ingredients selected from the group consisting of: meat; plant-based proteins; dairy -based proteins; egg-based proteins; fats; caloric carbohydrates; salt; flavour agents; preservatives; and vitamins and minerals.
[0017] The food product may comprise from 0.1 to 20wt% of the composition.
[0018] The food product may be a processed meat or plant-based meat alternative or restructured meat product selected from burgers, schnitzel, meatballs, sausages and lunch meats.
[0019] Also provided is a process for preparing the aforementioned composition comprising the following steps:• Providing a fibrous composition comprising insoluble com fiber, wherein the fibrous composition is obtainable as a side-stream from the wet-milling processing of com, wherein the fibrous composition has a water content of at least 40wt%, preferably at least 50wt%, more preferably at least 55wt%;• Treating the composition with a neutralizing agent to reduce the level of sulphur dioxide in the fibrous composition to below 40ppm, preferably less than 20 ppm, more preferably less than 10 ppm;• Drying the fibrous composition;• Obtaining a dried composition comprising insoluble com fiber having a water content of less than 15wt%, preferably less than 12wt%, more preferably less than 10wt%, most preferably less than 8wt%; and• Fractionating to obtain a D50 particle size of from 50 pm to 290 pm.
[0020] The invention also provides for the use of the aforementioned composition to manufacture a food product or food supplement.BRIEF DESCRIPTION OF THE FIGURES
[0021] In order that the present disclosure may be more readily understood, preferable embodiments thereof will now be described, by way of example only, with reference to the accompanying drawings, in which:
[0022] Figure 1 panels A-F are bar graphs representing in vitro bioaccessibility (ppm) of various phenolic acids at different phases of digestion (gastric phase 0-120 min, small intestinal phase 120-360 min) comparing digesta samples from two different corn fiber materials.
[0023] Figure 2 panels A-D are bar graphs representing in vitro bioaccessibility (ppm) of various steryl ferulates at different phases of digestion (gastric phase 0-120 min, small intestinal phase 120-360 min) comparing digesta samples from two different corn fiber materials.
[0024] Figure 3 is a bar graph comparing antioxidant activity of digesta samples from two different corn fiber materials at different phases of digestion (gastric phase 0-120 min, small intestinal phase 120-360 min).
[0025] The accompanying drawings illustrate various embodiments of systems, methods, and embodiments of various other aspects of the disclosure. Any person with ordinary skills in the art will appreciate that the illustrated element boundaries (e.g., boxes, groups of boxes, or other shapes) in the figures represent one example of the boundaries. It may be that in some examples one element may be designed as multiple elements or that multiple elements may be designed as one element. In some examples, an element shown as an internal component of one element may be implemented as an external component in another and vice versa. Furthermore, elements may not be drawn to scale. Non-limiting and non-exhaustive descriptions are described with reference to the following drawings. The components in the figures are not necessarily to scale, emphasis instead being placed upon illustrating principles.
[0026] Embodiments of the present disclosure will be described more fully hereinafter with reference to the accompanying drawings in which like numerals represent like elements throughout the several figures, and in which example embodiments are shown. Embodiments of the claims may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein.DETAILED DESCRIPTION OF THE INVENTION
[0027] Described herein is a composition for use in manufacturing processed meat, a method of making the same, and a food product produced therefrom.
[0028] Some of the terms used to describe the present invention are set out below:
[0029] “Insoluble com fiber” refers herein to both low and high molecular weight insoluble dietary fibers found in corn.
[0030] “Particle size” refers herein to the diameter of insoluble corn fiber particles in a composition. “D50 particle size” (also referred to as “average particle size”) is the median particle size whereby 50% of the particles in the sample by volume have a particle size greater than that value ad 50% of the particles in the sample by volume have a particle size less than that value. Methods and instruments for measuring particle size and particle size distribution D50 are well known in the art. For example, one can use laser diffraction, for instance using a laser diffraction analyser such as Mastersizer 3000.
[0031] “Bioactive compounds” are compounds, e.g., phytochemicals, found in foods which are capable of modulating metabolic processes. They exhibit beneficial health effects such as antioxidant activity. There is growing interest from manufacturers, led by consumer demand for healthy products, to incorporate bioactive compounds into food and beverages.
[0032] “Bioavailability” refers herein to the fraction of an ingested food, e.g., a bioactive compound, that is available for utilization by the body in physiological functions. In order to be bioavailable, bioactive compounds must first be released from the food matrix.
[0033] “Bioaccessibility” refers herein to the quantity of a compound that is released from its matrix in the gastrointestinal tract. Bioaccessibility can be evaluated using an in vitro digestion procedure as described herein.
[0034] “Antioxidant compounds” (also referred to as “antioxidants”) are compounds which exhibit antioxidant activity, meaning that they inhibit oxidation. Antioxidant activity may be measured in vitro using the ORAC assay described herein.
[0035] “Phenolic acids” are bioactive compounds found in cereals, such as corn. The two classes of naturally occurring phenolic acids are hydroxybenzoic acids and hydroxycinnamic acids, which are derived from benzoic and cinnamic acid, respectively. Phenolic acids exhibit high antioxidant activity and are thus beneficial for human health. Certain phenolic acids have also been shown to have anti inflammatory and anti-microbial functions, to affect blood pressure regulation, modulate glucose uptake, reduce fatigue, and have neuroprotective and prebiotic effects. Non-limiting examples of hydroxy cinnamic acids are ferulic acid, coumaric acid, caffeic acid, and chlorogenic acid. Non-limiting examples of hydroxybenzoic acids are gallic acid, sinapic acid, syringic acid, and vanillic acid.
[0036] “Steryl ferulates” are bioactive phytosterol compounds found in certain plants, including cereals. They are formed by esterification of the hydroxyl group of plant sterols with the carboxylic acid group of ferulic acid. They have been shown to possess antioxidant and cholesterol lowering activities. Non-limiting examples of steryl ferulates are campestanyl ferulate, oryzanol - campesteryl ferulate, oryzanol C -24 - methylenecycloartanyl ferulate, and sitosteryl ferulates.
[0037] The words "comprising," "having," "containing," and "including," and other forms thereof, are intended to be equivalent in meaning and be open ended in that an item or items following any one of these words is not meant to be an exhaustive listing of such item or items or meant to be limited to only the listed item or items.
[0038] As used herein, the singular forms "a," "an," and "the" and similar referents in the context of describing the elements (especially in the context of the following claims) include plural referents unless the context clearly dictates otherwise. For example, reference to "a substituent" encompasses a single substituent as well as two or more substituents, and the like. It is understood that any term in the singular may include its plural counterpart and vice versa, unless otherwise indicated herein or clearly contradicted by context.
[0039] Additionally, the phrase “consisting essentially of’ will be understood to include those elements specifically recited and those additionally elements that do not materially affect the basic and novel characteristics of the invention. The phrase “consisting of’ excludes any element not specified.
[0040] In addition, where features or aspects of the disclosure are described in terms of Markush groups, those skilled in the art will recognize that the disclosure is also thereby described in terms of any individual member or subgroup of members of the Markush group. Each of the narrower species and subgeneric groupings falling within the generic disclosure also form part of the invention. This includes the generic description of the invention with a proviso or negative limitation removing any subject matter form the genus, regardless of whether or not the excised material is specifically.
[0041] Throughout this document, particularly in terms of providing a written description, all values expressed in a range format should be interpreted in a flexible manner to include not only the numerical values explicitly recited as the limits of the range, but also to include all the individual numerical values or sub-ranges encompassed within that range as if each numerical value and sub-range is explicitly recited. Any listed range can be easily recognized as sufficiently describing and enabling the same range being broken down into at least equal halves, thirds,quarters, fifths, tenths, etc. For example, a range of “about 0.1% to about 5%” or “about 0.1% to 5%” should be interpreted to include not just about 0.1% to about 5%, but also the individual values (e.g., 1%, 2%, 3%, and 4%) and the sub-ranges (e.g., 0.1% to 0.5%, 1.1% to 2.2%, 3.3% to 4.4%) within the indicated range. As will also be understood by one skilled in the art all language such as “up to,” “at least,” “greater than,” “less than,” and the like, include the number recited and refer to ranges which can be subsequently broken down into subranges as discussed above. Finally, as will be understood by one skilled in the art, a range includes each individual member.
[0042] As used herein, the terms “for example,” “for instance,” “such as,” or “including” are meant to introduce examples that further clarify more general subject matter. Unless otherwise specified, these examples are provided only as an aid for understanding the applications illustrated in the present disclosure and are not meant to be limiting in any fashion.
[0043] As used herein, “about” will be understood by persons of ordinary skill in the art and will vary to some extent depending upon the context in which it is used. If there are uses of the term which are not clear to persons of ordinary skill in the art, given the context in which it is used, “about” will mean up to plus or minus 10% of the particular term.Insoluble corn fiber composition
[0044] The composition of the invention comprises at least 50wt% insoluble com fiber on a dry weight basis. Preferably, the composition comprises at least 55wt%, more preferably at least 60wt%, most preferably at least 65wt% of insoluble corn fiber on a dry weight basis. The amount of insoluble corn fiber can be measured according to method AO AC 2011.25. Alternatively, the composition may consist of or consist essentially of insoluble corn fiber.
[0045] Insoluble corn fiber composition refers to both low and high molecular weight insoluble dietary fibers found in corn. The composition comprises at least 50 wt.%, preferably at least 60 wt.%, more preferably at least 70 wt.%, on a dry weight basis of hemicellulose. Furthermore, the composition can comprise at least 20 wt.%, preferably at least 25 wt.%, more preferably at least 28 wt.% on a dry weight basis of cellulose. The composition preferably also comprises lignin, for instance at least 0.1 wt.%, or 1 wt.%, or at least 2 wt.%, or at least 5 wt.%, or at least 7 wt.%, or at least 8 wt.%, or at least 10 wt.% on a dry weight basis of lignin.
[0046] The composition has a D50 particle size of less than or equal to 290pm. Preferably, the D50 particle size is less than or equal to 250pm, or less than or equal to 220pm, or less than or equal to 200pm, or less than or equal to 180pm, or less than or equal to 150pm, or less than orequal to 120pm, or less than or equal to 110pm. More preferably, the D50 particle size is less than or equal to 250pm, and most preferably less than or equal to 220pm. The D50 particle size may be from 50pm to 250pm, or from 50pm to 220pm, or from 50pm to 200pm, or from 50pm to 180pm, or from 50pm to 150pm, or from 80pm to 120pm, or from 90pm to 110pm, or around 100pm. It has been surprisingly found that the unique particle size range of the composition results in several bioactive compounds present in the composition having superior bioaccessibility in comparison to other com fiber compositions having a different (e.g., larger) particle size. The higher bioaccessibility of such health promoting bioactive compounds allows for the composition to be used to boost the nutritional profile of processed food products.
[0047] The amount of various bioactive compounds in the composition also differs from known insoluble corn fiber compositions. The amount of bioactive compounds can be measured using Measurement method 1 as described below, or by any suitable method known in the art.
[0048] Specifically, the composition comprises less than 10,000ppm total hydroxycinnamic acids on dry weight basis, preferably less than 9,000ppm, more preferably less than 8,000ppm, most preferably less than 7,000ppm, or most preferably less than 6,000ppm, or most preferably less than 5,000ppm. The composition may comprise more than 2,000ppm total hydroxycinnamic acids on dry weight basis, preferably more than 2,500ppm, more preferably more than 3,000ppm, most preferably more than 3,500ppm, or most preferably more than 4,000ppm, or most preferably more than 4,500ppm.
[0049] In addition, the composition comprises greater than 50ppm, or greater than 55ppm, or greater than 60ppm, or greater than 65ppm, or greater than 70ppm, or greater than 75ppm, or greater than 80ppm, or greater than 85ppm, or greater than 90ppm, or greater than lOOppm, or greater than 350ppm total hydroxybenzoic acids on a dry weight basis, preferably greater than 375pm. The composition may comprise less than lOOppm total hydroxybenzoic acids on a dry weight basis, preferably less than 375pm.
[0050] Furthermore, the composition comprises greater than 1, lOOppm total steryl ferulates on a dry weight basis, preferably greater than l,250ppm, more preferably greater than l,500ppm, or more preferably greater than 2,000ppm, or more preferably greater than 5,000ppm. Furthermore, the composition may comprise less than 8,00ppm total steryl ferulates on a dry weight basis, preferably less than 7,500ppm, more preferably less than 7,000ppm.
[0051] Compared to the insoluble corn fiber composition described in WO 2022 / 060992 Al, the composition of the invention beneficially contains a significantly higher quantity of health promoting hydroxybenzoic acids and steryl ferulates.
[0052] The hydroxycinnamic acids may include ferulic acid, coumaric acid, caffeic acid, chlorogenic acid, and / or combinations thereof. The hydroxybenzoic acids may include gallic acid, sinapic acid, syringic acid, and vanillic acid, and / or combinations thereof. The steryl ferulates may include campestanyl ferulate, oryzanol - campesteryl ferulate, oryzanol C -24 - methylenecycloartanyl ferulate, sitosteryl ferulate, and / or combinations thereof.Bioaccessibility
[0053] Bioaccessibility of bioactive compounds may be measured using Measurement Method 2 as described below, or by any suitable method known in the art.
[0054] Several of the beneficial bioactive compounds in the composition have been shown to have good bioaccessibility according to in vitro digestion studies with measurement method 2. In particular, at least 60% of each steryl ferulate present in the composition is released within 360 minutes of digestion, preferably at least 65%, more preferably at least 70%, most preferably at least 75%.
[0055] Moreover, at least 60% of the oryzanol - campesteryl ferulate present in the composition is released within 360 minutes of digestion, preferably at least 65%, more preferably at least 70%, most preferably at least 75%.
[0056] Furthermore, at least 65% of the oryzanol C -24 - methylenecycloartanyl ferulate present in the composition is released within 360 minutes of digestion, preferably at least 70%, more preferably at least 75%, most preferably at least 80%.
[0057] In general, phytosterols (e.g., steryl ferulates) and phenolic acid compounds are released from the composition only or predominantly during the small intestinal phase of digestion. Without being bound by theory, it is hypothesized that the breakdown of digestive components of the composition by the host enzymes differently impacts the rate of release of different classes of bioactive compounds. Moreover, it has been demonstrated that there are distinct kinetic responses for different classes of bioactive compounds. For phenolic acids, bioaccessibility was found to increase with time of small intestinal digestion (i.e., slow release). Whereas for steryl ferulates, maximum release was found to occur at the early stage of small intestinal digestion (i.e., fast release).Antioxidant activity
[0058] Antioxidant activity may be measured using Measurement Method 3 as described below, or by any suitable method known in the art.
[0059] The composition may comprise antioxidant compounds. In addition to the phenolic acids and steryl ferulates mentioned above (which are known to have antioxidant activity), the antioxidant compounds in the composition may also include Di-isooctyl sebacate, pyrogallol, sanggenol O, Macrophyllol A (flavone), (9R, 10S-rel-(-)9, 10-bis (Acetyloxy)-9, 10 dihydro-5- methoxy-8,8-dimethyl-2-phenyl-4H,8H-benzo[l,2-b:3,4-b’]dipyran-4-one, 2-Tolylbiguanide, Pyruvic acid, 5-)-Methylchamanetin, or combinations thereof.
[0060] The antioxidant activity of the composition at the start of digestion was found to be constant during the gastric phase and increase during the small intestinal phase. This is consistent with the kinetics of release of the bioactive compounds described above. Advantageously, the composition has antioxidant activity of at least 100 pmol Trolox equiv / g at or after 3 hours of in vitro digestion according to measurement method 3, preferably at least 105 pmol Trolox equiv / g.
[0061] Overall, the high levels of certain beneficial bioactive compounds and superior antioxidant activity of the present composition is an indication that the composition can be used to develop functional foods with enhanced health benefits.Other components
[0062] The composition according to the invention consists of or essentially consists of components extracted or derived from corn, preferably extracted or derived from the wet-milling processing of com.
[0063] The composition according to the invention may comprise not only insoluble com fiber, but may also comprise, for instance, moisture (e.g., water), soluble fiber, starch, protein, and / or fat.
[0064] The composition according to the invention may comprise from 0.01 wt.% to 80 wt.%, preferably from 0.1 wt.% to 70 wt.%, or from 1 wt.% to 60 wt.% as the total amount of total dietary fiber on a dry weight basis. The amount of total dietary fiber is measured according to method AO AC 991.43.
[0065] The composition according to the invention may comprise of from 0.01wt% to 50wt%, preferably from 0.1 wt% to 45wt%, or from lwt% to 40wt as the total amount of starch, protein and fat on a dry weight basis.
[0066] The composition according to the invention may comprise of from 0.01wt% to 30wt%, preferably from 0.05wt% to 25wt%, or from 0.1 wt% to 20wt of starch on a dry weight basis. The amount of starch is measured according to method TS EN ISO 10520.
[0067] The composition according to the invention may comprise of from 0.01wt% to 25wt%, preferably from 0.05wt% to 20wt%, or from 0.1 wt% to 15wt of protein on a dry weight basis. The amount of protein is measured according to method AO AC 960.52.
[0068] The composition according to the invention may comprise of from 0.01wt% to 15wt%, preferably from 0.05wt% to 10wt%, or from 0. lwt% to 5wt of fat on a dry weight basis. The amount of lipids / fat is measured according to method TS EN ISO 659.
[0069] The composition according to the invention may comprise of from 0.01wt% to 15wt% moisture, preferably from 0.05wt% to 15wt%, or from 0.1 wt% to 10wt% of moisture on a dry weight basis.
[0070] The content of each component, i.e., moisture, starch, protein, and fat can be measured according to standard methods known in the art.
[0071] The composition according to the invention may have an ash content of from 0.01wt% to 5wt%, preferably from 0.05wt% to 0.3wt%, or from 0. lwt% to 2wt% on a dry weight basis. Ash content may be measured according to standard methods known in the art.Food products
[0072] The invention also relates to a food product comprising the composition according to the invention, and one or more other food ingredients.
[0073] The food product preferably comprises from 0.1 to 20wt%, preferably from 0.5 to 15wt%, more preferably from 1 to 10wt% of the composition according to the invention.
[0074] The food product can be selected from a processed meat or plant-based meat alternative or restructured meat product. These can be selected from burgers, schnitzel, meatballs, sausages (including but not limited to frankfurters, wieners, and bangers), and lunch meats (including but not limited to ham, salami, pastrami, mortadella, and meatloaf).
[0075] The one or more other food ingredients can be selected from one or more of: meat, such as beef, lamb, chicken, turkey, or pork; plant-based proteins, such as protein from legumes (e.g., pea, chickpea, fava, soya, lentils, edamame beans, mung bean), from nuts (e.g., peanuts, almonds, walnuts, cashew nuts, hazelnuts), from cereals (e.g., wheat, rice, corn), from pseudocereals (e.g., quinoa, amaranth, buckwheat), mycoprotein (e.g., Quorn®), from spirulina (algae), from potatoes, from seeds (e.g., chia seeds, hemp seeds), hydrolyzed or not; dairy -based proteins (from milk), hydrolyzed or not; egg-based proteins, hydrolyzed or not;fats, such as, but not limited to cocoa butter, coconut oil, canola oil, olive oil, sunflower oil, dairy butter; caloric carbohydrates, such as starch, dextrose, corn syrup, glucose-fructose syrup; salt; flavour agents, such as heme yeast extract, and colouring agents, such as beetroot extract; herbs and spices; preservatives, such as sodium nitrite; vitamins (such as Bl, niacin, B6, B2 and B12) and minerals (such as calcium, iron, potassium, zinc)The process
[0076] The composition of the invention is preferably entirely obtainable from a sidestream from the wet-milling processing of com.
[0077] The initial steps i) to v) in the process for making the composition of the invention are identical to those described in WO 2022 / 060992 Al, which is incorporated herein by reference in its entirety. For convenience, the initial method steps are summarised below. More details regarding each step can be found in the earlier disclosure. i) Providing a fibrous composition comprising insoluble corn fiber obtainable as a side-stream from the wet-milling processing of corn, wherein the fibrous composition has a water content of at least 40wt%, preferably at least 50wt%, more preferably at least 55wt%, most preferably at least 60wt%; ii) Treating the composition with a neutralizing agent to reduce the level of sulphur dioxide in the fibrous composition to below 40ppm, preferably less than 20 ppm, more preferably less than lOppm; iii) Drying the fibrous composition; iv) Obtaining a dried composition comprising insoluble com fiber having a water content of less than 15wt%, preferably less than 12wt%, more preferably less than 10wt%, most preferably less than 8wt%.
[0078] In order to obtain the composition of the present invention the product obtained from step iv) above is then fractionated to obtain a composition having a D50 particle size of less than or equal to 290pm. Preferably, the D50 particle size is less than or equal to 250pm, or less than or equal to 220pm, or less than or equal to 200pm, or less than or equal to 180pm, or less than or equal to 150pm, or less than or equal to 120pm, or less than or equal to 110pm. The D50particle size may preferably be from 50pm to 250pm, or from 50pm to 220pm, or from 50pm to 200pm, or from 50pm to 180pm or from 50pm to 150pm, or from 80pm to 120pm, or from 90pm to 110pm, or around 100pm.
[0079] This fractionation may be performed by any suitable method known in the art, such as milling / grinding followed by sieving. As the dried composition obtained in step iv) is elastic in nature, preferably the milling / grinding to reduce the particle size is done using a hammer mill. Other milling / grinding equipment equivalent to hammer mills capable of handling and milling such types of elastic compositions can also be used. The milled composition can then be sieved in order to obtain a composition having a D50 particle size of less than or equal to 290pm, or less than or equal to 180pm, or less than or equal to 150pm.MEASUREMENT METHODSMeasurement method 1 : LC-MS method for measuring bioactive compounds in digesta samples Sample preparation
[0080] Solvent compatibility was screened across a wide range of hydrophobicity to achieve optimal extractability of the range of target compounds. The optimal solvent system was determined to be approximately 70% acetonitrile in water. Other solvents tested were 0.1% formic acid in water, 40% methanol in water, 90% isopropanol in water, and 2: 1 ethyl acetate : i sopropanol .
[0081] The digesta samples were diluted into the appropriate solvent blend by taking 300 pL of digesta and adding 600 pL of pure acetonitrile. The samples were then centrifuged at 10,000 x to remove insoluble material. The supernatant (400 pl) was transferred to an autosampler vial for analysis by UHPLC-HRMS.
[0082] Commercial reference materials were purchased and calibration curve solutions were prepared in 70% acetonitrile. In the case of poorly soluble compounds, a concentrated stock was prepared first in either DMSO or isopropanol, as needed for solubility, before diluting into 70% acetonitrile for analysis by UHPLC-HRMS.Data collection and analysis
[0083] The chromatography was carried out on an Agilent Infinity II UHPLC system equipped with two Ace C18-PFP columns with 2.1 mm internal diameter, 150 mm length (300 mm total length), and 2 pm particles. The solvent system was water with 0.1% acetic acid (mobile phase A) and a mixture of 80% acetonitrile and 20% isopropanol with 0.1% acetic acid (mobilephase B). A gradient was employed according to table 1 below. The column was held at 50 °C, and 3 pL of sample was injected for the analysis. The LC system also had a UV detector in line before the MS, which collected data at 210 nm, 254 nm, 280 nm, and 320 nm, as well as full spectral data from 190 - 400 nm at a rate of 20 Hz. High-resolution mass spectrometry data was collected on a Thermo Q Exactive Plus instrument set at 35,000 resolution. The instrument was set to collect both positive and negative mode data throughout the run (switching mode). The scan range was 100 - 1500 m / z, 5 eV of declustering voltage was applied, and the S lens was set to 50.Table 1 : Gradient table
[0084] A calibration curve was constructed from a blend of the following commercial standards, with concentrations ranging from approximately 0.5 ppm through 50 ppm: Glucose, Choline, Citric Acid, Vitamin C (ascorbic acid), Thiamine, Gallic acid, Chlorogenic acid, Caffeic Acid, Vanillic Acid, Syringic Acid, Coumaric acid, Ferulic acid, Rutin (Quercetin + Glc + Rha), Naringin, Hesperidin, Diosmin, Cinnamic acid, Naringenin, Vitamin A (retinol), Zeaxanthin, Delta-tocopherol, Gamma-tocopherol, Alpha-tocopherol, Beta-sitosterol, Oryzanol A - Cycloartenyl ferulate, Oryzanol C - 24-Methylenecycloartanyl ferulate, Oryzanol - Campesteryl ferulate. All target compounds for which a commercial standard was not available were quantified by their closest structural analog.Acid hydrolysis
[0085] The feed samples were also treated with 6 N hydrochloric acid at room temperature for 4 hours to generate a chemically digested reference sample. After 4 hours, the samples were adjusted to pH ~3-5 with concentrated sodium hydroxide solution. The total volume of base wasmonitored closely, and the final sample was taken up to a full volume of 6.3 mL in order to match the dilution of the digesta samples before analysis.Measurement method 2: In vitro digestion assay for measuring bioaccessibility
[0086] Test materials were exposed sequentially to a saliva cocktail, a gastric cocktail, and a duodenal and bile cocktail in accordance with the recipes and conditions set out in table 2.Table 2: Enzyme cocktails and conditions& Nutrition Sciences 2018, 9, 711-734 (incorporated by reference).
[0087] Aliquots were taken at different time points during digestion and the amount of each bioactive compound present was measured according to measurement method 1 above. This value in ppm (pg / g sample) represents the bioaccessibility of the compound.Measurement method 3 : ORAC assay for measuring antioxidant activity
[0088] The method is based on the principle that antioxidants inhibit the oxidation of fluorescein by hydrogen atom transfer.MATERIALS-Fluorescein sodium salt (Sigma #46960)-AAPH = 2,2"-Azobis(2-methylpropionamidine)dihydrochloride (Sigma #440914) -TROLOX = 6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Sigma #238813)-75M M Phosphate buffer, pH 7.4-96-well clear bottom black walls microplate (Costar #3615)-EGCG (Sigma E4143)PREPARATION OF REAGENTS STOCKSAAPH: Weigh 82.8mg of AAPH into amber 4ml vials and store at -20°CTrolox Solution:1. Weigh 25mg Trolox and dissolve in 10ml 75mM phosphate buffer at pH 7.4 (makes 10 mM solution)2. Take 1ml of the lOmM solution (step 1), and add 9ml of 75 mM phosphate buffer pH 7.4 (makes 10ml of ImM stock solution)3. Divide into 1 ml aliquots stored in 15 mL conical tubes and freeze them at -20°C Fluorescein (4xl0~3mM) in 75mM phosphate buffer pH 7,4:1. Weigh 7.5mg fluorescein sodium salt and dissolve with 5ml buffer.2. Make a 1 / 10 dilution by mixing 1ml of the previous solution and 9ml of buffer.3. Take 0.1ml of the last dilution and mix with 9.9ml of buffer to make the 4xl0'3mM stock solution.4. Make 130pl aliquots in 0.5ml Eppendorf tubes and keep at -20°C.0, IM Phosphate Buffer pH 7,4:1. Prep Stocks: a. NaH2PO4.H2O: dissolve 27.6g NaH2PO4.H2O in distilled water to a total IL b. Na2HPO4: dissolve 28.4gNa2HPO4 in distilled water to a total IL2. Prep IL of 0. IM Phosphate buffer a. Mix 95ml NaH2PO4.H2O stock + 405ml Na2HPO4 stock + 500ml distilled water. b. Check pH and adjust to 7.43. Vacuum filter through 22um Amicon membrane.WORKING SOLUTIONS75mM Phosphate Buffer pH 7,4• mix 375ml of filtered 0.1M Phosphate buffer pH 7.4 stock solution and 125ml filtered distilled water.AAPH:• Add 2ml of 75mM phosphate buffer pH 7.4 to one vial containing 82.8mg AAPH to make working solution (153mM).• Mix gently. Prepare immediately before use. This is enough for one 96 well plate.Trolox:• Thaw one conical tube containing 1ml stock solution and add 9ml 75mM phosphate buffer pH 7.4. This makes lOOpM solution. (Protect from light)• Mix well and prepare serial dilutions as follows: o 50pM = 5ml lOOpM + 5ml 75mM phosphate buffer pH 7.4 o 25pM = 5ml 50pM + 5ml 75mM phosphate buffer pH 7.4 o 12.5pM = 5ml 250pM + 5ml 75mM phosphate buffer pH 7.4 o 6.125pM = 12. 5ml lOOpM + 5ml 75mM phosphate buffer pH 7.4Fluorescein:• Thaw one 130pl stock solution.• Prepare a conical 15ml tube with 9.9ml 75mM phosphate buffer pH 7.4 and add lOOpl of fluorescein stock solution.• Mix well.20 uM EGCG Solution (use 25 ul per well):• Make a 10 mM solution o Weigh 4.58 mg of EGCG (as accurately as possible) and dissolve in 10 ml phosphate buffer• Make a 1 mM solution o Take 1 ml of the 10 mM solution and add 9 ml Phosphate buffer• Make a 100 pM solution o Take 1 ml of the 1 mM solution and add 9 ml Phosphate buffer• Make a 20 pM solution (working solution) o Take 1 ml of the 1 mM solution and add 4 ml Phosphate buffer.PREPARATION OF SAMPLES• Take 100 pl of each triplicate and mix• Make a 1 / 100 dilution in 75 mM Phosphate buffer pH 7.4 as follows: o Make a 1 / 10 dilutions: 100 pl of each sample-mix plus 900 pl buffer o Make a 1 / 100 dilution: 100 pl of each 1 / 10 dilution plus 900 pl buffer■ Analysis is done in triplicate (technical repeats): 25 pl sample per wellASSAY PROTOCOL■ Prepare reader: pre-heat chamber to 37°C and open a new experiment. Choose protocol ORAC no injection■ Prepare a special optics black side plate■ Add 300pl distilled water to each outside well■ Add 150pl fluorescein working solution to each experimental well (use multi-channel pipette with 6 tips)■ Add 25pl of the different Trolox dilutions or 25pl of samples to corresponding wells in triplicate (use multi-channel pipette with 3 tips)■ Put inside reader chamber and press read: first step is incubation for 30min at 37°C■ While incubation occurs, prepare the AAPH working solution■ When incubation is finished, the plate comes out of the reader and, working as fast as possible, add 25 pl of AAPH working solution (use multi-channel pipette with 6 tips)■ Press OK and the reader will start the read: first it will shake the plate and then it will take one read every min for Ih. Results will be reported as net AUC and concentrations.EXAMPLES
[0089] The following are non-limiting examples that discuss, with reference to tables and figures, the advantages of the present invention. The examples set forth herein are merely examples among other possible examples.Example 1:
[0090] The bioaccessibility of various bioactive compounds was tested for digesta samples from two different types of corn fiber using measurement method 2 described above. The digesta samples were:• Sample 1 : Insoluble corn fibre composition having a D50 particle size of 100pm. -“CF1”• Sample 2 (comparative): Insoluble corn fiber according to WO 2022 / 060992 Al (D50 particle size of 300pm to 700pm) - “CF2”The results are shown in figure 1 A-F (phenolic acids) and figure 2 A-D (steryl ferulates) and table 3 below.Table 3: Bioaccessibility data for samples 1 and 2.Example 2:
[0091] Antioxidant activity of digesta samples for two different types of corn fiber was measured and compared using the ORAC assay described in measurement method 3 above. The samples were:• Sample 3: Insoluble com fibre having a D50 particle size of 100pm - “CF1”• Sample 4 (comparative) - Insoluble corn fiber according to WO 2022 / 060992 Al (D50 particle size of 300pm to 700pm) - “CF2”
[0092] The results are shown in figure 3.Example 3:
[0093] The amount of bioactive compounds was measured using Measurement method 1 as described above on insoluble corn fibre samples having smaller particle sizes according to the invention that were obtained by appropriately milling and sieving to achieve the desired D50. The results are shown in Table 4:Table 4: Bioactives analysis measured using LCMS on Samples 3, 4 and 5.
[0094] The features disclosed in the foregoing description, or the following claims, or the accompanying drawings, expressed in their specific forms or in terms of a means for performing the disclosed function, or a method or process for attaining the disclosed result, as appropriate, may, separately, or in any combination of such features, be utilized for realizing the invention in diverse forms thereof.
[0095] Although certain example aspects of the invention have been described, the scope of the appended claims is not intended to be limited solely to these examples. The claims are to be construed literally, purposively, and / or to encompass equivalents.
[0096] In addition, it is to be understood that the phraseology or terminology employed herein, and not otherwise defined, is for the purpose of description only and not of limitation. Any use of section headings is intended to aid reading of the document and is not to be interpreted as limiting; information that is relevant to a section heading may occur within or outside of that particular section. In the event of inconsistent usages between this document and those documents so incorporated by reference, the usage in the incorporated reference should be considered supplementary to that of this document; for irreconcilable inconsistencies, the usage in this document controls.
[0097] The invention may also broadly consist in the parts, elements, steps, examples and / or features referred to or indicated in the specification individually or collectively in any and all combinations of two or more said parts, elements, steps, examples and / or features. In particular, one or more features in any of the embodiments described herein may be combined with one or more features from any other embodiment(s) described herein.
[0098] Protection may be sought for any features disclosed in any one or more published documents referenced herein in combination with the present disclosure.
Claims
CLAIMS1. A composition comprising at least 50wt% insoluble corn fiber on a dry weight basis, and having a D50 particle size of less than or equal to 290pm.
2. A composition according to claim 1 consisting of insoluble corn fiber.
3. A composition according to claim 1, wherein the D50 particle size is less than or equal to 220pm, or less than or equal to 180pm.
4. A composition according to any one of the preceding claims, wherein the composition comprises: less than 10,000ppm total hydroxy cinnamic acids on dry weight basis; and greater than 30ppm total hydroxybenzoic acids on a dry weight basis; and greater than l,100ppm total steryl ferulates on a dry weight basis.
5. A composition according to claim 4, wherein the hydroxy cinnamic acids are selected from ferulic acid, coumaric acid, caffeic acid, chlorogenic acid, and / or combinations thereof.
6. A composition according to claim 4, wherein the hydroxybenzoic acids are selected from gallic acid, sinapic acid, syringic acid, and vanillic acid, and / or combinations thereof.
7. A composition according to claim 4, wherein the steryl ferulates are selected from campestanyl ferulate, oryzanol - campesteryl ferulate, oryzanol C -24 - methylenecycloartanyl ferulate, sitosteryl ferulate, and / or combinations thereof.
8. A composition according to any one of claims 4 to 7, wherein according to measurement method 2, at least 60% of each steryl ferulate present in the composition is released within 360 minutes of in vitro digestion.
9. A composition according to any one of claims 4 to 8, wherein according to measurement method 2,at least 60% of the oryzanol - campesteryl ferulate present in the composition is released within 360 minutes of in vitro digestion; and / or at least 65% of the oryzanol C -24 - methylenecycloartanyl ferulate present in the compositon is released within 360 minutes of in vitro digestion.
10. A composition according to any preceding claims , comprising antioxidant compounds selected from Di-isooctyl sebacate, pyrogallol, sanggenol O, Macrophyllol A (flavone), (9R, 10S-rel-(-)9, 10-bis (Acetyloxy)-9, 10 dihydro-5-methoxy-8,8-dimethyl-2-phenyl-4H,8H- benzo[l,2-b:3,4-b’]dipyran-4-one, 2-Tolylbiguanide, Pyruvic acid, 5-)-Methylchamanetin, or combinations thereof.
11. A composition according to any one of the preceding claims, wherein the composition has antioxidant activity of at least 100 pmol Trolox equiv / g at or after 3 hours of in vitro digestion according to measurement method 3.
12. The composition according to any one of the preceding claims being entirely obtainable from a side-stream from the wet-milling processing of corn.
13. A food product comprising the composition according to any one of the preceding claims, and one or more other food ingredients selected from the group consisting of: meat; plant-based proteins; dairy-based proteins; egg-based proteins; fats; caloric carbohydrates; salt; flavor agents; preservatives; and vitamins and minerals.
14. The food product according to claim 13 wherein the food product comprises from 0.1 to 20wt% of the composition.
15. The food product according to claim 13 or 14 wherein the food product is a processed meat or plant-based meat alternative or restructured meat product selected from burgers, schnitzel, meatballs, sausages and lunch meats.
16. A process for preparing the composition according to any one of claims 1 to 12 comprising the following steps:a) Obtaining a dried composition comprising insoluble com fiber having a water content of less than 15wt%, preferably less than 12wt%, more preferably less than 10wt%, most preferably less than 8wt%; and b) Milling the dried composition; and c) Sieving the dried composition to obtain a composition having a D50 particle size of less than or equal to 290pm, or less than or equal to 180pm.
17. A process according to claim 16, further comprising the following steps before step (a): i) Providing a fibrous composition comprising insoluble com fiber, wherein the fibrous composition is obtainable as a side-stream from the wet-milling processing of com, wherein the fibrous composition has a water content of at least 40wt%, preferably at least 50wt%, more preferably at least 55wt%; ii) Treating the composition with a neutralizing agent to reduce the level of sulphur dioxide in the fibrous composition to below 40ppm, preferably less than 20 ppm, more preferably less than 10 ppm; iii) Drying the fibrous composition to obtain a dried composition comprising insoluble com fiber having a water content of less than 15wt%, preferably less than 12wt%, more preferably less than 10wt%, most preferably less than 8wt%.
18. Use of the composition according to any one of claims 1 to 12 to manufacture a food product or food supplement.
Citation Information
Patent Citations
Preparation method for high water-holding capacity and water-insolubility corn dietary fiber
CN102356881A
Corn fiber oil its preparation and use
US5843499A
Compositions comprising insoluble corn fiber
WO2022060992A1
